Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eisai’s New 340B Contract Pharmacy Restrictions to Exclude Arkansas and Louisiana

Eisai contract pharmacy
Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New BMS Contract Pharmacy Policy May Target Hospital Self-Distribution, Say Attorneys

Bill Von Oehsen
William von Oehsen, principal at the law firm Powers, said the SUSTAIN ACT is "not going to live or die based on the user fee."
Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Following Response Deadline, Next Steps in Senator’s 340B Probe Unclear

Bill Cassidy
Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.
The deadline has passed for two health systems to respond to an influential senator’s probe into 340B revenue, and at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Says 340B Lump Sum Payments Fueled Increase in Part B Premiums, Deductibles

CMS building
CMS said planned Medicare Part B premium increases are partly the result of the proposed lump sum payment for previous illegal 340B hospital cuts.
Federal regulators recently said planned out-of-pocket increases for Medicare beneficiaries are due, in part, to the proposed lump sum payment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Study, Health Center’s Patients Laud its 340B Drug Assistance Program

A recent study suggested a 340B cash discount program was associated with better outcomes for patients with diabetes.
A recent study found positive patient benefits from a 340B cash discount program. Low-income patients said saving money on injectable [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS and HRSA Urge Judge to Reject Health Center’s Take on 340B Patient Definition

Genesis Health Care building and signage
Genesis Health Care's proposed 340B patient definition would remove all limits on dispensing 340B drugs, HHS and HRSA told a federal district judge.
Federal healthcare agencies recently told a federal district judge that backing a South Carolina health center’s interpretation of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audit Finds Fourth Drugmaker Owes Refunds

Drugmaker RedHill Biopharma owes repayments to 340B covered entities, a finalized HRSA audit found.
A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Fighting 340B Expulsion Gets Temporary Reprieve

Insight Hospital and Medical Center Chicago has an additional 31 days to fight its expulsion from the 340B program, a federal district judge ordered.
A federal district judge has granted a Chicago hospital an additional 31 days to fight its expulsion from the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Advocates Meet with Regulators on Lump Sum Rule

Boris Bershteyn, an attorney representing AHA, will advocate for for changes in the 340B lump sum re-payment rule before federal regulators.
Two hospital advocacy groups are meeting with federal healthcare regulators to press their case for changes in the 340B lump [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live